Neurology

Ceribell

Revenue-stage company selling the world’s first brain monitor for point-of-care seizure triage and treatment optimization.

Red Tree Participation
Co-investor in Series C and Series D

Red Tree Board Observer

Heath Lukatch, Ph.D.

Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Observer

Heath Lukatch, Ph.D.

Red Tree Participation
Co-investor in Series C and Series D

Ceribell

Neurology
Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Observer

Heath Lukatch, Ph.D.

Red Tree Participation
Co-investor in Series C and Series D